- Home
- AUPH vs CHY Comparison
AUPH vs CHY Comparison
Compare AUPH & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- CHY
- Stock Information
- Founded
- AUPH 1993
- CHY 2003
- Country
- AUPH Canada
- CHY United States
- Employees
- AUPH N/A
- CHY N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- CHY Investment Managers
- Sector
- AUPH Health Care
- CHY Finance
- Exchange
- AUPH Nasdaq
- CHY Nasdaq
- Market Cap
- AUPH 1.1B
- CHY 839.8M
- IPO Year
- AUPH 1999
- CHY N/A
- Fundamental
- Price
- AUPH $8.77
- CHY $10.99
- Analyst Decision
- AUPH Strong Buy
- CHY
- Analyst Count
- AUPH 2
- CHY 0
- Target Price
- AUPH $11.50
- CHY N/A
- AVG Volume (30 Days)
- AUPH 1.4M
- CHY 128.3K
- Earning Date
- AUPH 07-31-2025
- CHY 01-01-0001
- Dividend Yield
- AUPH N/A
- CHY 10.11%
- EPS Growth
- AUPH N/A
- CHY N/A
- EPS
- AUPH 0.27
- CHY N/A
- Revenue
- AUPH $247,295,000.00
- CHY N/A
- Revenue This Year
- AUPH $12.15
- CHY N/A
- Revenue Next Year
- AUPH $18.31
- CHY N/A
- P/E Ratio
- AUPH $31.76
- CHY N/A
- Revenue Growth
- AUPH 29.20
- CHY N/A
- 52 Week Low
- AUPH $5.20
- CHY $9.97
- 52 Week High
- AUPH $10.67
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- AUPH 66.00
- CHY 66.22
- Support Level
- AUPH $7.71
- CHY $10.46
- Resistance Level
- AUPH $8.29
- CHY $10.60
- Average True Range (ATR)
- AUPH 0.25
- CHY 0.09
- MACD
- AUPH 0.03
- CHY 0.01
- Stochastic Oscillator
- AUPH 84.40
- CHY 98.68
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.